Man Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-344,418
Closed -$65.8M 2010
2019
Q4
$65.8M Buy
344,418
+113,758
+49% +$20.5M 0.22% 93
2019
Q3
$38.8M Buy
230,660
+82,486
+56% +$13.4M 0.14% 162
2019
Q2
$24.8M Buy
148,174
+74,049
+100% +$10.3M 0.09% 276
2019
Q1
$10.9M Buy
74,125
+9,554
+15% +$1.39M 0.04% 532
2018
Q4
$8.63M Sell
64,571
-93,311
-59% -$15.3M 0.04% 516
2018
Q3
$30.1M Sell
157,882
-31,385
-17% -$5.77M 0.11% 197
2018
Q2
$31.6M Buy
189,267
+124,662
+193% +$20M 0.13% 158
2018
Q1
$10.9M Buy
+64,605
New +$10.8M 0.05% 444

Other funds holding AGN

Man Group's AGN Position: Q1 2020 in Review

Man Group sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 344,418 shares — an estimated $65.8M sold.

Man Group first reported a position in AGN in Q1 2018 and held it in 8 quarters. The position peaked at $65.8M in Q4 2019. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Man Group reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Man Group sold 344,418 Allergan plc shares in Q1 2020, an estimated $65.8M.
  • Man Group first reported a position in Allergan plc in Q1 2018 and held it in 8 quarters.
  • Man Group's Allergan plc position peaked at $65.8M in Q4 2019.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Man Group's 13F filing for Q1 2020, filed 15 May 2020.